Les meilleurs podcasts American College Of Cardiology (2024)

1
JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Strain Surveillance During Chemotherapy to Improve Cardiovascular Outcomes: The SUCCOUR-MRI Trial 15:36

2d ago15:36

15:36

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and Tom Marwick, MBBS, PhD, MPH discuss the study design, findings and the use of strain surveillance during chemotherapy to improve cardiovascular outcomes.

1
JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Effects of Intensive vs Standard Blood Pressure Control on Cardiovascular Outcomes in Cancer Survivors: Results from the SPRINT Randomized Trial ... 9:44

2d ago9:44

9:44

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and Yichao Xiao, MD discuss the study design, findings, future research questions and the potential clinical impact on the management of blood pressure in cancer survivors.

1
JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Sacubitril/Valsartan in Primary Prevention of Cancer-Therapy Related Cardiac Dysfunction in Breast Cancer Patients 11:31

2d ago11:31

11:31

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC, Yen-Wen Liu, MD, PhD, Professor of Medicine, FESC and Yu-Ling Hsu, MD discuss the study design, findings and potential implications for clinical practice and future research questions for the prevention of cancer-therapy related cardiac dysfunction in breast cancer patients.…

1
JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Use of Polygenic Risk Score for Prediction of Heart Failure in Cancer Survivors 12:09

2d ago12:09

12:09

Tom Marwick, MBBS, PhD, MPH and Sivatharshini Ramalingam, MD discuss discuss the study design and findings, as well as the future use and potential development of cardio-oncology specific risk scores for prediction of heart failure in cancer survivors.

1
Adverse Cardiovascular Outcomes in Patients with Obstructive Sleep Apnea and Obesity: Metabolic Surgery versus Usual Care 12:06

4d ago12:06

12:06

In this episode, Dr. Valentin Fuster reviews a groundbreaking study comparing metabolic surgery to traditional care for patients with obesity and obstructive sleep apnea. The research shows that metabolic surgery significantly lowers the risk of major cardiovascular events and mortality, highlighting the need for a multifaceted approach to treating…

1
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF 10:33

4d ago10:33

10:33

In the September 17, 2024 issue of JACC, Valentin Fuster discusses a study on sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, which shows modest improvements in health status among patients with worsening heart failure. While the study highlights sotagliflozin's benefits, it also points out gaps in understanding its full impact and emphasizes the …

1
Prognostic value of plasma IgG N-glycome traits in pulmonary arterial hypertension 10:56

4d ago10:56

10:56

In this September 17, 2024 JACC issue, Dr. Zhi Jian Zhang and colleagues unveil a groundbreaking study on pulmonary arterial hypertension (PAH) that identifies plasma IgG fucosylation and glycan traits as promising prognostic markers. This research not only enhances survival predictions beyond current models but also opens intriguing possibilities …

1
JACC - September 17, 2024 Issue Summary 23:09

4d ago23:09

23:09

In this episode, Valentin Fuster reviews the September 17, 2024, JACC issue, highlighting pivotal studies on metabolic surgery's impact on cardiovascular risk in obstructive sleep apnea patients, and the potential of DPP-4 inhibitors in aortic valve calcification. He also discusses the benefits of Sitagliptin for heart failure and the prognostic va…

1
Effect of Evogliptin on the Progression of Aortic Valvular Calcification 10:45

4d ago10:45

10:45

In the September 17, 2024 issue of JACC, Dr. Jai Quan Song and colleagues explore whether the DPP-4 inhibitor, abrogating, can slow the progression of aortic valvular calcification. Although the primary endpoint was not met, the study's promising secondary results and ongoing research into related therapies suggest potential future breakthroughs in…

1
Genotype Guided Antiplatelet Therapy: JACC Review Topic of the Week 12:11

4d ago12:11

12:11

In this episode of JACC, Valentin Fuster examines genotype-guided antiplatelet therapy, emphasizing its potential to tailor treatments based on genetic variants for improved patient outcomes. While promising, the approach faces challenges like testing delays and variable patient responses that need addressing for broader implementation.…

1
RESHAPE-HF2 Trial Findings | ESC 2024 6:03

7d ago6:03

6:03

Dr. Marcus Anker, presenting at ESC, discussed the RESHAPE HF2 trial's findings on transcatheter edge-to-edge repair for secondary mitral regurgitation, published in JACC with Aakriti Gupta, MD, FACC, JACC Executive Associate Editor.

1
Effect of Screening for Undiagnosed Atrial Fibrillation and on Stroke Prevention | ESC Congress 14:18

8d ago14:18

14:18

Xiaoxi Yao, MPH, MS, PhD, FACC, JACC Associate Editor, interviews Renato Lopes, MD, PhD, FACC, author of the GUARD-AF trial published in JACC and presented at ESC Congress 2024.

1
Mineralocorticoid Antagonism in Heart Failure | ESC 2024 5:29

8d ago5:29

5:29

Biykem Bozkurt, MD, PhD, FACC, Editor-in-Chief of JACC: Heart Failure, and Akshay S. Desai, MD, MPH, FACC, Deputy Editor of JACC: Heart Failure interview Andrew J. Sauer, MD, on a state-of the-art review examining the current data on mineralocorticoid antagonism in heart failure, published in JACC: Heart Failure and presented at ESC.…

1
Pakistan Registry of Echocardiographic Screening in Pregnant Women | ESC 2024 7:42

8d ago7:42

7:42

Candice K. Silversides, MD, FACC, Editor-in-Chief of JACC: Advances, and Sabha Bhatti, MD, FACC, discuss Dr. Bhatti's ESC late-breaking study on echocardiographic screening of pregnant women in Pakistan.

1
Cardio-Obstetrics: Pearls for Every Cardiac Practitioner 36:45

9d ago36:45

36:45

Join our special guests, Drs. Lauren Lastinger from The Ohio State University and Sharon Roble from OhioHealth, as we review common issues in cardio-obstetrics for the cardiac practitioner. We will review pearls for managing common cardiovascular conditions during pregnancy, evaluation of cardiac symptoms during pregnancy, common medication pitfall…

1
JACC Asia - August 1, 2024 Issue Summary 13:55

10d ago13:55

13:55

In this episode of the JACC: Asia podcast, Dr. Magnus O. Wijkman highlights key studies from the September 2024 issue, including groundbreaking research on the interplay between cardiometabolic disorders and depression, gender disparities in interventional cardiology, and the efficacy of new treatments for hypertension. The podcast also covers adva…

1
JACC Asia - Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary Hypertension 3:38

10d ago3:38

3:38

In this episode of the JACC: Asia podcast, Dr. Magnus O. Wijkman reviews a pivotal study comparing the angiotensin receptor neprilysin inhibitor sacubitril alisarmin with olmesartan for treating primary hypertension in Chinese patients. The trial found sacubitril alisarmin to be more effective in reducing blood pressure and well-tolerated, suggesti…

1
Insights from the SEQUOIA-HCM Trial and SEQUOIA-HCM CRM Substudy | ESC 2024 21:47

10d ago21:47

21:47

Michelle M. Kittleson, MD, PhD, FACC, JACC Associate Editor and John A. Spertus, MD, MPH, FACC discuss the evaluation of the cardiac myosin inhibitor, aficamten, on patient-reported health status in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) as part of the SEQUOIA trial. The study utilized the Kansas City Cardiomyopathy…

1
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome 8:50

11d ago8:50

8:50

In the September 10, 2024, issue of JACC, the study by Dr. Doron Seeker and colleagues investigates alirocumab’s impact on cardiovascular outcomes related to triglyceride levels. Despite effectively lowering LDL cholesterol, alirocumab did not show significant clinical benefit through triglyceride reduction, suggesting that its efficacy may be limi…

1
Association of Postnatal Opioid Exposure and 2-year Neurodevelopmental Outcomes in Infants Undergoing Cardiac Surgery 8:28

11d ago8:28

8:28

In this September 10th, 2024 issue of Jack, Dr. Michael Ogburn's study highlights a troubling association between high postnatal opioid exposure and poorer neurodevelopmental outcomes in infants who have undergone cardiac surgery. Despite careful adjustments for confounding factors, increased opioid use was linked to significant deficits in cogniti…

1
Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood 10:05

11d ago10:05

10:05

In the September 10, 2024, JACC issue, Dr. Valentin Fuster highlights a pivotal study showing that a single cholesterol measurement in young adults can predict future cardiovascular risk with remarkable accuracy. He underscores the need for early lipid screening and novel long-acting treatments to improve long-term cardiovascular health, stressing …

1
JACC - September 10, 2024 Issue Summary 21:43

11d ago21:43

21:43

In the September 10, 2024, issue of JACC, Dr. Valentin Fuster highlights groundbreaking research on lipid exposure in early adulthood and its link to later cardiovascular events, the importance of early and serial assessments in cardiogenic shock, and the impact of triglyceride levels on cardiovascular outcomes with alirocumab. He also discusses th…

1
Serial Shock Severity Assessment Within Seventy-Two Hours after Diagnosis: A Cardiogenic Shock Working Group Report 11:18

11d ago11:18

11:18

In the September 10, 2024, JACC issue, Dr. Valentin Fuster discusses a pivotal study on cardiogenic shock, revealing that early and frequent reassessment within the first 24 hours is crucial for predicting patient outcomes. The study underscores the critical nature of early intervention and highlights the rapid progression seen in many patients, em…

1
Serial Shock Severity Assessment: Some Answers. Still Many Questions. | ESC 2024 11:36

13d ago11:36

11:36

Rasha K. Al-Lamee, MD, PhD, JACC Deputy Editor and Navin K. Kapur MD discuss the work from the Cardiogenic Shock Working Group, which is an academic research consortium comprising ~40 hospitals in the U.S. and internationally.

1
Insights from RESHAPE-HF2 Trial | ESC 2024 13:30

13d ago13:30

13:30

Aakriti Gupta, MD, FACC, JACC Executive Associate Editor, and Stefan D. Anker, MD, discuss the insights from the RESHAPE-HF2 trial - an eight-year study on the efficacy of transcatheter edge-to-edge repair for mitral valve regurgitation in patients with heart failure.

1
A Secondary Analysis of DANFLU-1 Trial - High vs Standard Dose Influenza Vaccine in CKD | ESC 2024 16:15

13d ago16:15

16:15

Khurram Nasir, MBBS, FACC, JACC Associate Editor and Tor Biering-Sorenson, MD, MPH, PhD, discuss the importance of influenza vaccines for patients with chronic kidney disease (CKD), particularly in the context of the DANFLU-1 study.

1
Updates from the STEP-HFpEF Trial | ESC 2024 21:12

14d ago21:12

21:12

Neha J. Pagidipati, MD, FACC, JACC Associate Editor and Mikhail Kosiborod, MD, FACC discuss an exciting secondary analysis of the STEP-HFpEF program, shedding light on the groundbreaking findings related to heart failure and obesity.

1
Updates from the SELECT Trial: Outcomes by Sex | ESC 2024 18:56

14d ago18:56

18:56

Neha J. Pagidipati, MD, FACC, JACC Associate Editor and Subodh Verma MD, PhD explore a secondary analysis of the SELECT trial, a landmark study investigating the cardiovascular benefits of semaglutide in people with obesity or overweight without diabetes.

1
An Analysis From the SELECT Trial - COVID-19| ESC 2024 6:50

14d ago6:50

6:50

Harlan Krumholz, MD, FACC, JACC Editor-in-Chief, and Benjamin M. Scirica, MD, MPH, FACC, discuss the surprising benefits of semaglutide beyond weight loss and cardiovascular health from the SELECT trial, which investigated the effects of semaglutide on COVID-19 outcomes and non-cardiovascular deaths in patients with obesity and cardiovascular disea…

Podcasts qui valent la peine d'être écoutés

American College Of Cardiology Podcasts

Podcasts qui valent la peine d'être écoutés

Guide de référence rapide